The Effect of Dietary Salt Intake on Immune Function in Patients With Multiple Sclerosis
NCT02282878 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 14
Last updated 2021-04-19
Summary
The purpose of this work is to investigate the influence of dietary salt intake on immune function in multiple sclerosis (MS) subjects and healthy controls. This study primarily tests the hypothesis that higher dietary salt intake will be associated with a higher frequency of pathogenic Th17 cells and impaired function of protective regulatory T cells. If a relationship between dietary salt intake and immune function is observed, this study will also test: a) whether this relationship is unique to MS subjects or whether it is also present in healthy controls, and b) whether healthier immune function can be restored by restricting dietary salt intake.
Conditions
Interventions
- DIETARY_SUPPLEMENT
-
High/Low Sodium Diet
All patients will receive 2 weeks of the high sodium diet followed by a 1 week washout and then 2 weeks of the low sodium diet
Sponsors & Collaborators
-
Yale University
lead OTHER
Principal Investigators
-
David Hafler, MD · Yale University
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2014-09-30
- Primary Completion
- 2018-12-19
- Completion
- 2019-12-08
Countries
- United States
Study Locations
More Related Trials
-
Evaluation of Nutritional Status and Fatigue in Patients With Multiple Sclerosis
NCT02008669 ·Status: COMPLETED
-
Examining the Impact of an Online, Non-restrictive Diet Among Persons With Multiple Sclerosis
NCT05712408 ·Status: COMPLETED ·Phase: NA
-
Low Fat Diet for Fatigue in MS
NCT03322982 ·Status: UNKNOWN ·Phase: NA
-
TCV -01-002: T-Cell Vaccination in the Treatment of Probable Multiple Sclerosis
NCT00228228 ·Status: UNKNOWN ·Phase: PHASE3
-
Serum 25-Hydroxyvitamin D and Neurological Disability in Multiple Sclerosis
NCT07123337 ·Status: COMPLETED
-
Efficacy of COVID-19 Vaccination in Patients With Multiple Sclerosis Treated With Immune Modulating Medication
NCT04796584 ·Status: TERMINATED
-
COVID-19 Booster Vaccination in Persons With Multiple Sclerosis
NCT05081271 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Methionine Intake Microbiota
NCT07283328 ·Status: RECRUITING ·Phase: NA
-
Covid-19 Vaccine Immune Response in Multiple Sclerosis
NCT05269888 ·Status: ACTIVE_NOT_RECRUITING
-
Impact of Vitamin A Supplementation on Immune System in Multiple Sclerosis Patients
NCT01225289 ·Status: COMPLETED ·Phase: PHASE4
-
Pilot and Feasibility Trial of a Telehealth Dietary Intervention for MS
NCT03372187 ·Status: COMPLETED ·Phase: NA
-
Low Fat Diet and Multiple Sclerosis
NCT00852722 ·Status: COMPLETED ·Phase: PHASE1
-
High-intensity Resistance Training in People With Multiple Sclerosis Experiencing Fatigue
NCT04562376 ·Status: COMPLETED ·Phase: NA
-
The Effect of a Mediterranean Diet on Quality of Life in Multiple Sclerosis Patients
NCT06764563 ·Status: RECRUITING ·Phase: NA
-
Effect of Vitamin D Replacement on Immune Function and Cognition in MS Patients
NCT01952483 ·Status: COMPLETED
-
Determination of Compliance to Mediterranean Diet, Impacts on Walking and Quality of Life in Multiple Sclerosis
NCT05777629 ·Status: UNKNOWN
-
Evaluation of a Modified Paleolithic Dietary Intervention in the Treatment of Relapsing-Remitting Multiple Sclerosis
NCT02687919 ·Status: COMPLETED ·Phase: NA
-
Time Restricted Eating Outcomes in Multiple Sclerosis
NCT04389970 ·Status: COMPLETED ·Phase: NA
-
Multiple Sclerosis Produces Cardiovascular Subclinical Dysfunction
NCT03001284 ·Status: UNKNOWN
-
Assessing Induction of Type II (M2) Monocytes/Macrophages in Patients Receiving Gilenya.
NCT02225977 ·Status: COMPLETED
-
Vitamin D3 Supplementation and the T Cell Compartment in Multiple Sclerosis (MS)
NCT00940719 ·Status: COMPLETED ·Phase: NA
-
T Cell Vaccination in Patients With Progressive Multiple Sclerosis
NCT01448252 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Immunodeficiency in MS
NCT04447937 ·Status: UNKNOWN
-
Estimating Prevalence of COVID-19 Infection and SARS-CoV-2 Antibodies in MS Patients
NCT04682548 ·Status: COMPLETED
-
Study of Circadian Focused Light Therapy in Progressive Multiple Sclerosis
NCT06261528 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1